Interestingly, they found that the α2-adrenergic receptor agonist dexmedetomidine reversed these changes, reducing ferroptosis by increasing GPX4 expression and decreasing iron concentration, thereby alleviating sepsis-induced cardiomyocyte damage.465. The gene discussed is GPX4; the disease is Sepsis.